膽固醇測試市場：市場規模（按細分市場）、份額、監管、報銷、預測（~2033 年）

進行膽固醇測試是為了檢查血液中膽固醇水平是否升高。 血液膽固醇水平升高會增加心臟病、中風和周邊動脈疾病的風險。 高血壓的盛行率是最大的因素之一。

測量血液膽固醇有幾個參數，包括高密度脂蛋白（HDL）、低密度脂蛋白（LDL）和總膽固醇。 HDL 是 "好膽固醇" 的標記，而 LDL 是 "壞膽固醇" 的標記。 總膽固醇是血液中膽固醇的總量，包括 "好" 膽固醇和 "壞" 膽固醇。

膽固醇檢測模式分為高密度脂蛋白（HDL）膽固醇檢測、低密度脂蛋白（LDL）膽固醇檢測、總膽固醇檢測、多參數膽固醇檢測。

本報告深入探討了全球膽固醇檢測市場，提供競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。Masu。

目錄

目前市面上的膽固醇測試及競爭狀況

• 對主要產業趨勢的見解
• 膽固醇測試按細分市場劃分的總市場收入以及 2015 年至 2033 年的市場前景
• 有關數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 膽固醇檢測市場的SWOT分析
• 膽固醇測試市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Abstract

Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Cholesterol Tests market for the year 2020 and beyond. Cholesterol test is performed to identify elevated levels of cholesterol present in the blood. Elevated levels of cholesterol in the blood may increase the risk of heart attack, stroke, and peripheral artery disease. The prevalence of hypertension is one of the largest drivers.

There are a few parameters for the determination of cholesterol in the blood, such as high-density lipoproteins (HDL), low-density lipoproteins (LDL), and total cholesterol. HDL is a marker of "good cholesterol", whereas LDL is known as a marker of "bad cholesterol"; total cholesterol is the overall amount of cholesterol in the blood, including both "good" and "bad" cholesterols.

Cholesterol Tests model is segmented into High-Density Lipoprotein (HDL) Cholesterol Lab Tests, Low-Density Lipoprotein (LDL) Cholesterol Test, Total Cholesterol Test and Multi-parameter Cholesterol Test.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Cholesterol Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Cholesterol Tests market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Cholesterol Tests market.
• Competitive dynamics insights and trends provided for Cholesterol Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Danaher Corp, Helena Laboratories Corp, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, Siemens AG, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Sekisui Chemical Ltd, Alfa Wassermann Inc, Merck KGaA, Sinocare Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Cholesterol Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Cholesterol Tests market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Cholesterol Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cholesterol Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Cholesterol Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable